Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM
RESEARCH TOOLSreports
Holding MIRM?
Track your performance easily
See the Price Targets and Ratings of:
MIRM Analyst Ratings
Strong Buy
8 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MIRM Stock 12 Month Forecast
Average Price Target
$59.88
▲(45.73% Upside)
| Highest Price Target$69.00 | Average Price Target$59.88 | Lowest Price Target$44.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
Reiterated
10/17/24
H.C. Wainwright
Reiterated
10/11/24
JMP Securities
Reiterated
08/08/24
Evercore ISI
Assigned
08/08/24
Morgan Stanley
Reiterated
08/08/24
Stifel Nicolaus
Reiterated
08/08/24
Robert W. Baird
Assigned
08/08/24
Cantor Fitzgerald
$45→$60
Buy
46.02%
Upside
Reiterated
08/07/24
Mirum Pharmaceuticals (MIRM) Receives a Buy from Cantor Fitzgerald
Citi
$64
Buy
55.76%
Upside
Reiterated
06/27/24
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (NASDAQ: MIRM), Vigil Neuroscience Inc (NASDAQ: VIGL) and Cooper Co (NASDAQ: COO)
J.P. Morgan
$31→$39
Buy
-5.09%
Downside
Reiterated
06/18/24
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (NASDAQ: MIRM), Beam Therapeutics (NASDAQ: BEAM) and Ovid Therapeutics (NASDAQ: OVID)
Best Analysts Covering Mirum Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy MIRM and Sell After:
1 Month
xxx
Success Rate
20/32 ratings generated profit
Average Return
+3.48%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 62.50% of your transactions generating a profit, with an average return of +3.48% per trade.
3 Months
xxx
Success Rate
22/32 ratings generated profit
Average Return
+10.62%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +10.62% per trade.
1 Year
2 Years
xxx
Success Rate
32/32 ratings generated profit
Average Return
+56.95%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +56.95% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MIRM Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Oct 24
Strong Buy
14
23
26
24
12
Buy
6
7
6
6
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
30
32
30
16
Each month's total comprises the sum of three months' worth of ratings.
MIRM Financial Forecast
MIRM Stock Forecast FAQ
What is MIRM’s average 12-month price target, according to analysts?
Based on analyst ratings, Mirum Pharmaceuticals Inc’s 12-month average price target is $59.88.
What is MIRM’s upside potential, based on the analysts’ average price target?
Mirum Pharmaceuticals Inc has 45.73% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MIRM a Buy, Sell or Hold?
Mirum Pharmaceuticals Inc has a consensus rating of Strong Buy which is based on 8 buy ratings, 0 hold ratings and 0 sell ratings.
What is Mirum Pharmaceuticals Inc’s price target?
The average price target for Mirum Pharmaceuticals Inc is $59.88. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $69.00 ,the lowest forecast is $44.00. The average price target represents 45.73% Increase from the current price of $41.09.
The highest analyst price target is $69.00 ,the lowest forecast is $44.00. The average price target represents 45.73% Increase from the current price of $41.09.
What do analysts say about Mirum Pharmaceuticals Inc?
Mirum Pharmaceuticals Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of MIRM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.